BCSF — Bain Capital Specialty Finance, Inc. stock price, charts and financials
QT44Bain Capital Specialty Finance, Inc.Bain Capital Specialty Finance, Inc. (NYSE: BCSF) is a Financial Services company in the Asset Management industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 10.87 | EPS (ttm) | 1.14 | Insider Own | 30.18% | Shs Outstand | 64.87M | Perf Week | 0.49% |
| Market Cap | 805.67M | Forward P/E | 8.39 | EPS next Y | 1.48 | Insider Trans | 0.01% | Shs Float | 64.09M | Perf Month | -1.66% |
| Enterprise Value | 2.24B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 1.89% | Perf Quarter | -9.61% |
| Income | 73.64M | P/S | 4.10 | EPS this Y | 46.35% | Inst Trans | - | Short Ratio | 3.42 | Perf Half Y | -5.84% |
| Sales | 196.66M | P/B | 0.74 | EPS next Y | -11.29% | ROA | 2.83% | Short Interest | 1.21M | Perf YTD | -10.71% |
| Book/sh | - | P/C | 8.88 | EPS next 5Y | -8.40% | ROE | 6.57% | 52W High | 16.20 -21.59% | Perf Year | -16.76% |
| Cash/sh | - | P/FCF | 8.88 | EPS past 3/5Y | -2.30% 61.12% | ROIC | 3.64% | 52W Low | 12.09 5.08% | Perf 3Y | -14.99% |
| Dividend Est. | 1.68 (13.23%) | EV/EBITDA | 23.03 | Sales past 3/5Y | 12.25% 25.42% | Gross Margin | 61.16% | Volatility | 2.56% 2.22% | Perf 5Y | -18.72% |
| Dividend TTM | 1.89 (14.88%) | EV/Sales | 11.41 | EPS Y/Y TTM | -38.38% | Oper. Margin | 49.58% | ATR (14) | 0.31 | Perf 10Y | - |
| Dividend Ex-Date | Jun 15, 2026 | Quick Ratio | 0.33 | Sales Y/Y TTM | -7.51% | Profit Margin | 37.42% | RSI (14) | 44.34 | Recom | 2.75 |
| Dividend Gr. 3/5Y | 12.22% 6.40% | Current Ratio | 0.33 | EPS Q/Q | -16.00% | SMA20 | -1.90% | Beta | 0.64 | Target Price | 14.00 |
| Payout | 169.23% | Debt/Eq | 1.33 | Sales Q/Q | 3.85% | SMA50 | -2.46% | Rel Volume | 0.98 | Prev Close | 12.42 |
| Employees | - | LT Debt/Eq | 0.78 | Earnings | Aug 10 | SMA200 | -6.57% | Avg Volume | 334.39K | Price | 12.70 |
| IPO Date | Nov 15, 2018 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -0.76% 0.91% | Net Debt/EBITDA | 14.76 | Volume | 326,625 | Change | 2.25% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight | $17 → $14 |
| Dec-19-25 | Upgrade | Keefe, Bruyette & Woods | Market Perform → Outperform | |
| May-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight | $12 → $17 |
| May-11-23 | Upgrade | Wells Fargo | Underweight → Equal Weight | $12 |
| Jul-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight | |
| Mar-01-21 | Upgrade | Wells Fargo | Underweight → Equal Weight | |
| Jun-29-20 | Downgrade | B of A Securities | Buy → Neutral | |
| Jan-27-20 | Downgrade | Keefe, Bruyette & Woods | Outperform → Market Perform | |
| Jan-26-20 | Downgrade | Keefe, Bruyette& Woods | Outperform → Perform | |
| Jan-15-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Bain Capital Specialty Finance, Inc. functions as a business development company (BDC) whose primary focus is providing direct debt solutions to companies in the middle market segment. The fund's investment mandate is broad, covering a spectrum of debt instruments. This includes various forms of secured senior debt, such as first-lien, stretch senior, and second-lien facilities. It also invests in hybrid financing structures like unitranche loans, as well as subordinated or junior capital, which encompasses mezzanine debt and other junior securities. Furthermore, the firm engages in the secondary acquisition of assets or portfolios, primarily comprising corporate debt from middle-market businesses. Generally, Bain Capital Specialty Finance targets companies that generate annual earnings before interest, taxes, depreciation, and amortization (EBITDA) between $10 million and $150 million.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 197 | 239 | 213 | 218 | 169 | 175 | 77 | 161 | 74 | |
| Cost of Goods Sold Incl. D&A | 77 | 55 | 75 | 80 | 52 | 51 | 63 | 66 | 1 | |
| Gross Profit | 120 | 184 | 138 | 138 | 117 | 124 | 14 | 95 | 73 | |
| Selling, General and Administrative Excl. Other | 12 | 0 | 14 | 11 | 9 | 9 | 9 | 8 | 4 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 11 | 3 | 0 | 0 | 1 | -5 | -4 | -11 | 15 | |
| Operating Income | 99 | 181 | 124 | 127 | 106 | 120 | 9 | 98 | 69 | |
| Interest Expense | 82 | 81 | 75 | 80 | 52 | 51 | 63 | 66 | 24 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 62 | 2 | 75 | 80 | 52 | 51 | 63 | 66 | -19 | |
| Net Income Before Taxes | 78 | 103 | 124 | 127 | 106 | 120 | 9 | 98 | 27 | |
| Income Taxes | 4 | 4 | 4 | 3 | 1 | 0 | 0 | 0 | 0 | |
| Consolidated Net Income | 74 | 99 | 119 | 123 | 105 | 120 | 8 | 98 | 27 | |
| Net Income From Continuing Operations | 74 | 99 | 119 | 123 | 105 | 120 | 8 | 98 | 27 | |
| Net Income | 74 | 99 | 119 | 123 | 105 | 120 | 8 | 98 | 27 | |
| EPS (Recurring) | 1.14 | 1.52 | 1.85 | 1.91 | 1.63 | 1.86 | 0.14 | 1.87 | 0.69 | |
| EPS (Basic, Before Extraordinaries) | 1.14 | 1.52 | 1.85 | 1.91 | 1.63 | 1.86 | 0.14 | 1.87 | 0.69 | |
| EPS (Diluted) | 1.14 | 1.52 | 1.85 | 1.91 | 1.63 | 1.86 | 0.14 | 1.87 | 0.68 | |
| EBITDA | 99 | 183 | 124 | 127 | 106 | 120 | 9 | 98 | 51 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 11.14 | 9.15 | 9.47 | 7.89 | 7.30 | 8.18 | 86.64 | 10.57 | 24.66 | |
| Price To Sales Ratio | 4.19 | 3.78 | 5.35 | 4.49 | 4.58 | 5.65 | 9.29 | 6.38 | 8.84 | |
| Gross Margin | 60.91 | 76.99 | 64.79 | 63.30 | 69.23 | 70.86 | 18.18 | 59.01 | 98.65 | |
| Operating Margin | 50.25 | 75.73 | 58.22 | 58.26 | 62.72 | 68.57 | 11.69 | 60.87 | 93.24 | |
| Net Margin | 37.56 | 41.42 | 55.87 | 56.42 | 62.13 | 68.57 | 10.39 | 60.87 | 36.49 | |
| Shares Outstanding | 65 | 65 | 65 | 65 | 65 | 65 | 59 | 52 | 39 | |
| Market Capitalization | 826 | 904 | 1,139 | 980 | 774 | 989 | 716 | 1,028 | 654 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Rusnak-Carlson Sabrina | General Counsel | Mar 03 '26 | Buy | 12.55 | 2,300 | 28,865 | 9,560 | Mar 03 |
| Richer Clare Stack | Director | Mar 17 '25 | Buy | 16.43 | 1,530 | 25,138 | 20,835 | Mar 17 |
| Richer Clare Stack | director: | Aug 10 '22 | Buy | 14.59 | 3,400 | 49,606 | 16,784 | Aug 10 |
| Hough Thomas A. | director: | Mar 25 '22 | Buy | 15.94 | 6,272 | 99,974 | 27,680 | Mar 25 |
| Richer Clare Stack | director: | Mar 03 '22 | Buy | 16.18 | 3,090 | 49,997 | 12,792 | Mar 04 |
| Butte Amy | Director | Feb 25 '22 | Buy | 15.86 | 1,300 | 20,618 | 5,213 | Feb 25 |
| Richer Clare Stack | Director | May 11 '21 | Buy | 15.90 | 1,563 | 24,852 | 9,087 | May 11 |
| Hawkins Jeffrey B. | Director | Dec 03 '20 | Buy | 12.50 | 18,204 | 227,550 | 100,001 | Dec 03 |
| Ewald Michael A | President and CEO | Dec 03 '20 | Buy | 12.52 | 4,000 | 50,080 | 69,995 | Dec 03 |
| Dornaus Sally F | Chief Financial Officer | Aug 19 '20 | Buy | 10.43 | 2,500 | 26,075 | 2,500 | Aug 19 |
| Hough Thomas A. | Director | Jun 05 '20 | Option Exercise | 10.22 | 19,623 | 200,547 | 19,623 | Jun 08 |
| MARGOLIS JAY | Director | Jun 05 '20 | Option Exercise | 10.22 | 28,856 | 294,909 | 28,856 | Jun 08 |
| Richer Clare Stack | Director | Jun 05 '20 | Option Exercise | 10.22 | 6,771 | 69,200 | 6,771 | Jun 08 |
| Butte Amy | Director | Jun 05 '20 | Option Exercise | 10.22 | 3,500 | 35,770 | 3,500 | Jun 08 |
| Boyle Michael John | Vice President and Treasurer | Jun 05 '20 | Option Exercise | 10.22 | 24,000 | 245,280 | 24,543 | Jun 08 |